Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Rekha Parameswaran"'
Autor:
Giulia Petrone, Charles Gaulin, Andriy Derkach, Ashwin Kishtagari, Mark E. Robson, Rekha Parameswaran, Eytan M. Stein
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
We aim to identify predictors of therapy-related myeloid neoplasms (t-MN) in patients with breast cancer (BC) and cytopenias to determine the timing of bone marrow biopsy (BMBx). Patients with BC and cytopenias who were referred for BMBx between 2002
Externí odkaz:
https://doaj.org/article/07691a1fc7e04c9a9636decbe4dbbbdd
Autor:
Cy R. Wilkins, Jocelyn Ortiz, Leah J. Gilbert, Shen Yin, Jodi V. Mones, Rekha Parameswaran, Simon Mantha, Gerald A. Soff
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Background Chemotherapy‐induced thrombocytopenia (CIT) is common during treatment with antineoplastic therapies and may adversely impact chemotherapy dose intensity. There is no approved therapy for CIT. In our recent phase II randomized s
Externí odkaz:
https://doaj.org/article/55728aab962a421eb55e38afe5a64bc0
Autor:
Giulia Petrone, Charles Gaulin, Andriy Derkach, Ashwin Kishtagari, Mark E. Robson, Rekha Parameswaran, Eytan M. Stein
Publikováno v:
Haematologica. 108(1)
We aim to identify predictors of therapy-related myeloid neoplasms (t-MN) in patients with breast cancer (BC) and cytopenias to determine the timing of bone marrow biopsy (BMBx). Patients with BC and cytopenias who were referred for BMBx between 2002
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e33ac9d708f02c5a2fed650544c675
https://pubmed.ncbi.nlm.nih.gov/35770528
https://pubmed.ncbi.nlm.nih.gov/35770528
Autor:
Cy R. Wilkins, Jocelyn Ortiz, Leah J. Gilbert, Shen Yin, Jodi V. Mones, Rekha Parameswaran, Simon Mantha, Gerald A. Soff
Publikováno v:
Research and practice in thrombosis and haemostasis. 6(3)
Chemotherapy-induced thrombocytopenia (CIT) is common during treatment with antineoplastic therapies and may adversely impact chemotherapy dose intensity. There is no approved therapy for CIT. In our recent phase II randomized study, romiplostim led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5d33fc062585cde78dd306c422c15cb
https://pubmed.ncbi.nlm.nih.gov/35582038
https://pubmed.ncbi.nlm.nih.gov/35582038
Autor:
Rocio Perez-Johnston, Allen W. Zhang, Jacqueline Predmore, Anna Kaltsas, Anthony F. Daniyan, Miguel Perales, Tobias M. Hohl, Rekha Parameswaran, Sejal Morjaria, Dhruvkumar Patel, Justin Jee, Ying Taur, Wei Zhou
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 74(4)
Background Neutropenia is commonly encountered in cancer patients. Recombinant human granulocyte colony-stimulating factor (G-CSF, filgrastim), a cytokine that initiates proliferation and differentiation of mature granulocytes, is widely given to onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0948042d44f817564f075909691114f
https://pubmed.ncbi.nlm.nih.gov/32817981
https://pubmed.ncbi.nlm.nih.gov/32817981
Autor:
Anna Kaltsas, Dhruvkumar Patel, Tamara Nawar, Rocio Perez-Johnston, Sejal Morjaria, Sham Mailankody, Anthony F. Daniyan, Rekha Parameswaran
Publikováno v:
American Journal of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0d926c6182b5d182a1dcc0e3048999
Autor:
Cy Wilkins, Jodi V. Mones, Leah Gilbert, Rekha Parameswaran, Gerald A. Soff, Jocelyn Ortiz, Simon Mantha, Shen Yin
Publikováno v:
Blood. 138:2075-2075
Background: Chemotherapy induced thrombocytopenia (CIT) is common, adversely impacts chemotherapy relative dose intensity, and may adversely impact cancer control. There is no approved therapy for CIT. In our recent phase II study of solid tumor pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6878ac124a7264f760aa9ba718b60f06
https://doi.org/10.1182/blood-2021-145958
https://doi.org/10.1182/blood-2021-145958
Autor:
Gerald A. Soff, Gemma Bendheim, Jeanette Batista, Debra M. Sarasohn, Sean M. Devlin, Cy Wilkins, Rekha Parameswaran, Ghassan K. Abou-Alfa, Jodi V. Mones, Simon Mantha, Nancy E. Kemeny, Andrea Cercek, Yimei Miao
Publikováno v:
Journal of Clinical Oncology
PURPOSE Chemotherapy-induced thrombocytopenia (CIT) leads to delay or reduction in cancer treatment. There is no approved treatment. METHODS We conducted a phase II randomized trial of romiplostim versus untreated observation in patients with solid t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a79aa6fd150326eedf67e0d4fe28f2ed
https://pubmed.ncbi.nlm.nih.gov/31545663
https://pubmed.ncbi.nlm.nih.gov/31545663
Autor:
Simon Mantha, Rekha Parameswaran, Miguel-Angel Perales, Emily Lauer, Leyla Shune, Sean M. Devlin, Marissa Lubin, Andromachi Scaradavou, Valkal Bhatt, Doris M. Ponce, N A Kernan, Juliet N. Barker
Publikováno v:
Bone Marrow Transplantation. 51:1579-1583
Autoimmune hemolysis (AH) and immune thrombocytopenic purpura (ITP) are recognized complications after cord blood transplantation (CBT). We evaluated the incidence and characteristics of AH/ ITP after double-unit CBT in a day 100 landmark analysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00467f9ac605ec2f33d041f2ccb76196
https://doi.org/10.1038/bmt.2016.228
https://doi.org/10.1038/bmt.2016.228
Autor:
Debra M. Sarasohn, Simon Mantha, Stephen Harnicar, Gagandeep Brar, Rekha Parameswaran, Yimei Miao, Eva S. Laube, Jonathan Wills, Gerald A. Soff, Samantha Stefanik, Patrick Samedy
Publikováno v:
Journal of Thrombosis and Thrombolysis
Low-molecular weight heparin (LMWH) has been the standard of care for treatment of venous thromboembolism (VTE) in patients with cancer. Rivaroxaban was approved in 2012 for the treatment of pulmonary embolism (PE) and deep vein thrombosis (DVT), but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57095490d87491e1cc5b13dcfd129fa6
http://europepmc.org/articles/PMC5318467
http://europepmc.org/articles/PMC5318467